Canaccord lowered the firm’s price target on Enovis (ENOV) to $50 from $58 and keeps a Buy rating on the shares. The firm updated their model to largely reflect our new 2027 estimates, with some updates to 2026 estimates as well
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV: